Seattle Genetics

TIVDAK

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TIVDAK – J9273

Manufacturer:

Seattle Genetics

Name:

TIVDAK

HCPCS Code Descriptor:

Injection, tisotumab vedotin-tftv, 1 mg

Category:

J Code

HCPCS:

J9273

NDC(s):

51144-0003-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TIVDAK is an Oncology drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9273 is aligned to the drug TIVDAK.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/22

HCPCS Effective Date:

4/1/22

HCPCS Short Description:

Inj tisotu vedotin-tftv, 1mg

Billing and Coding Guide:

https://www.seagensecure.com/assets/pdfs/Tivdak/TIVDAK-Billing-and-Coding-Guide.pdf

Patient Assistance:

https://www.seagensecure.com/patient/tivdak

TIVDAK - J9273